Download The Management of Cervical Cancer PowerPoint Presentation

Login   OR  Register

Iframe embed code :

Presentation url :


Description :

Available The Management of Cervical Cancer powerpoint presentation for free download which is uploaded by honey an active user in belonging ppt presentation Health & Wellness category.

Tags :

The Management of Cervical Cancer

Home / Health & Wellness / Health & Wellness Presentations / The Management of Cervical Cancer PowerPoint Presentation

The Management of Cervical Cancer PowerPoint Presentation

Ppt Presentation Embed Code   Zoom Ppt Presentation

About This Presentation

Description : Available The Management of Cervical Cancer powerpoint presentation for free download which is uploa... Read More

Tags : The Management of Cervical Cancer

Published on : Feb 24, 2014
Views : 459 | Downloads : 0

Download Now

Share on Social Media


User Presentation
SlidesFinder: Advertise with us
Related Presentation
Free PowerPoint Templates
Donuts Free PowerPoint Template


Views : 611

Meditation Free PowerPoint Template


Views : 212

Injecting Free PowerPoint Template


Views : 260

Email Free PowerPoint Template


Views : 276

Obesity Free PowerPoint Template


Views : 647

Happy Birthday Free PowerPoint Template

Happy Birthday

Views : 384

Heart Free PowerPoint Template


Views : 280

Nature Abstract Free PowerPoint Template

Nature Abstract

Views : 274

Agriculture Free PowerPoint Template


Views : 643

Butterfly Free PowerPoint Template


Views : 390

Synapse Free PowerPoint Template


Views : 515

Laboratory Free PowerPoint Template


Views : 457

Airplane Free PowerPoint Template


Views : 217

Dollar Free PowerPoint Template


Views : 265

Herbal Pills Free PowerPoint Template

Herbal Pills

Views : 377

Dental Brush Free PowerPoint Template

Dental Brush

Views : 301

Bales Free PowerPoint Template


Views : 363

Quit Smoking Free PowerPoint Template

Quit Smoking

Views : 414

Slide 1 - The Management of Cervical , Vulvar and Vaginal Cancers Kerry J. Rodabaugh, M.D. Division of Gynecologic Oncology University of Nebraska Medical Center
Slide 2 - Incidence: global public health issue 450,000 – 500,000 women diagnosed each year worldwide In developing countries, it is the most common cause of cancer death 340,000 deaths in 1985
Slide 3 - United States Incidence 15,000 women diagnosed annually 4,800 annual deaths
Slide 4 - Mortality Rates <2/100,000: Finland, France, Greece, Israel, Japan, Korea, Spain, Thailand 2.7/100,000: USA 12-15.9/100,000: Chile, Costa Rica, Mexico
Slide 5 - Lifetime risk of developing cervical cancer 5% - South America 0.7% - USA
Slide 6 - Cervical CA Risk Factors Early age of intercourse Number of sexual partners Smoking Lower socioeconomic status High-risk male partner Other sexually transmitted diseases Up to 70% of the U.S. population is infected with HPV
Slide 7 - Screening Guidelines for the Early Detection of Cervical Cancer, American Cancer Society 2003 Screening should begin approximately three years after a women begins having vaginal intercourse, but no later than 21 years of age. Screening should be done every year with regular Pap tests or every two years using liquid-based tests. At or after age 30, women who have had three normal test results in a row may get screened every 2-3 years. However, doctors may suggest a woman get screened more if she has certain risk factors, such as HIV infection or a weakened immune system. Women 70 and older who have had three or more consecutive Pap tests in the last ten years may choose to stop cervical cancer screening. Screening after a total hysterectomy (with removal of the cervix) is not necessary unless the surgery was done as a treatment for cervical cancer. American Cancer Society. Cancer Facts & Figures. 2004. Atlanta, GA; 2005
Slide 8 - Pap Smear Single Pap false negative rate is 20%. The latency period from dysplasia to cancer of the cervix is variable. 50% of women with cervical cancer have never had a Pap smear. 25% of cases and 41% of deaths occur in women 65 years of age or older.
Slide 9 - Clinical Presentation CIN/CIS/ACIS – asymptomatic Irregular vaginal bleeding Vaginal discharge Pelvic pain Leg edema Bowel/bladder symptoms
Slide 10 - Physical Findings Exophytic, cauliflower like mass Cervical ulcer, friable or necrotic Firm “barrel-shaped” cervix Hydronephrosis Anemia Weight loss
Slide 11 - ppt slide no 11 content not found
Slide 12 - Histology Squamous 85-90% Adenocarcinoma 10-15% Lymphoma Neuroendocrine/small cell Melanoma
Slide 13 - Route of Spread Cervical cancer spreads by direct invasion or by lymphatic spread Vascular spread is rare
Slide 14 - Staging Physical exam Cervical biopsies Chest x-ray IVP (Ct scan) Barium enema, cystoscopy, proctoscopy Surgical staging
Slide 15 - Staging Stage I – confined to the cervix IA1 – <3mm depth of invasion IA2 – stromal invasion 3-5mm in depth or <7 mm in width IB1- tumor < 4 cm IB2 - tumor > 4 cm in diameter Stage II – extension beyond cervix IIA – upper 2/3 of vagina IIB – Parametrial involvement
Slide 16 - Staging Stage III IIIA – lower 1/3 of vagina IIIB – extension to pelvic sidewall or hydronephrosis Stage IV IVA – bladder or rectal mucosa IVB – distant metastases
Slide 17 - ppt slide no 17 content not found
Slide 18 - 5 year survival rates Stage IA 90-100% Stage IB 70-90% Stage II 50-60% Stage III 30-40% Stage IV 5%
Slide 19 - Therapy Cervical conization Simple hysterectomy Radical hysterectomy Radiation therapy with chemosensitization
Slide 20 - ppt slide no 20 content not found
Slide 21 - ppt slide no 21 content not found
Slide 22 - ppt slide no 22 content not found
Slide 23 - 5 year Survival Stage I 70% Stage II 51% Stage III 33% Stage IV 17%
Slide 24 - Pros and Cons Surgery Bladder dysfunction Vesico/uretero fistula Bowel obstruction Ovarian preservation Vaginal preservation Radiation Sigmoiditis Rectovaginal fistula Bowel obstruction Vesico/uretero fistula Ovarian failure
Slide 25 - Radiation Therapy External Beam Whole pelvis or para-aortic window 4000-6000 cGy Over 4-5 weeks Brachytherapy Intracavitary or interstitial 2000-3000 cGy Over 2 implants
Slide 26 - ppt slide no 26 content not found
Slide 27 - ppt slide no 27 content not found
Slide 28 - Recurrent Cervical Cancer 10-20% of patients treated with radical hysterectomy Recurrence has an 85% mortality 83% are diagnosed within the first two years of post-treatment surveillance
Slide 29 - Recurrent Cervical Cancer Radiation Pelvic exenteration Palliative chemotherapy
Slide 30 - Vulvar Cancer 3870 new cases 2005 870 deaths Approximately 5% of Gynecologic Cancers American Cancer Society. Cancer Facts & Figures. 2004. Atlanta, GA; 2005
Slide 31 - Vulvar Cancer 85% Squamous Cell Carcinoma 5% Melanoma 2% Sarcoma 8% Others
Slide 32 - Vulvar Cancer Biphasic Distribution Average Age 70 years 20% in patients UNDER 40 and appears to be increasing
Slide 33 - Vulvar Cancer Etiology Chronic inflammatory conditions and vulvar dystrophies are implicated in older patients Syphilis and lymphogranuloma venereum and granuloma inguinal HPV in younger patients Tobacco
Slide 34 - Vulvar Cancer Paget’s Disease of Vulva 10% will be invasive 4-8% association with underlying Adenocarcinoma of the vulva
Slide 35 - ppt slide no 35 content not found
Slide 36 - ppt slide no 36 content not found
Slide 37 - Symptoms Most patients are treated for “other” conditions 12 month or greater time from symptoms to diagnosis
Slide 38 - Symptoms Pruritus Mass Pain Bleeding Ulceration Dysuria Discharge Groin Mass
Slide 39 - Symptoms May look like: Raised Erythematous Ulcerated Condylomatous Nodular
Slide 41 - Tumor Spread Very Specific nodal spread pattern Direct Spread Hematogenous
Slide 42 - Staging Based on TNM Surgical Staging Tumor size Node Status Metastatic Disease
Slide 43 - Staging Stage I T1 N0 M0 Tumor ≤ 2cm IA ≤1 mm depth of Invasion IB 1 mm or more depth of invasion
Slide 44 - Staging Stage II T2 N0 M0 Tumor >2 cm Confined to Vulva or Perineum
Slide 45 - Staging Stage III T3 N0 M0 T3 N1 M0 T1 N1 M0 T2 N1 M0 Tumor any size involving lower urethra, vagina, anus OR unilateral positive nodes
Slide 46 - Staging Stage IVA T1 N2 M0 T2 N2 M0 T3 N2 M0 T4 N any M0 Tumor invading upper urethra, bladder, rectum, pelvic bone or bilateral nodes
Slide 47 - Staging Stage IVB Any T Any N M1 Any distal mets including pelvic nodes
Slide 48 - Treatment Primarily Surgical Wide Local Excision Radical Excision Radical Vulvectomy with Inguinal Node Dissection Unilateral Bilateral Possible Node Mapping, still investigational
Slide 49 - Treatment Local advanced may be treated with Radiation plus Chemosensitizer Positive Nodal Status 1 or 2 microscopic nodes < 5mm can be observed 3 or more or >5mm post op radiation
Slide 50 - Treatment Special Tumor Verrucous Carcinoma Indolent tumor with local disease, rare mets UNLESS given radiation, becomes Highly malignant and aggressive Excision or Vulvectomy ONLY
Slide 51 - Vulva 5 year survival Stage I 90 Stage II 77 Stage III 51 Stage IV 18 Hacker and Berek, Practical Gynecologic Oncology 4th Edition, 2005
Slide 52 - Recurrence Local Recurrence in Vulva Reexcision or radiation and good prognosis if not in original site of tumor Poor prognosis if in original site
Slide 53 - Recurrence Distal or Metastatic Very poor prognosis, active agents include Cisplatin, mitomycin C, bleomycin, methotrexate and cyclophosphamide
Slide 54 - Melanoma 5% of Vulvar Cancers Not UV related Commonly periclitoral or labia minora
Slide 55 - Melanoma Microstaged by one of 3 criteria Clark’s Level Chung’s Level Breslow
Slide 56 - Melanoma Treatment Wide local or Wide Radical excision with bilateral groin dissection Interferon Alpha 2-b
Slide 57 - Vaginal Carcinoma 2140 new cases projected 2005 810 deaths projected 2005 Represents 2-3% of Pelvic Cancers American Cancer Society. Cancer Facts & Figures. 2004. Atlanta, GA; 2005
Slide 58 - Vaginal Cancer 84% of cancers in vaginal area are secondary Cervical Uterine Colorectal Ovary Vagina Fu YS, Pathology of the Uterine Cervix, Vagina and Vulva, 2nd ed. 2002
Slide 59 - Vaginal Carcinoma Squamous Cell 80-85% Clear Cell 10% Sarcoma 3-4% Melanoma 2-3%
Slide 60 - Clear Cell Carcinoma Associated with DES Exposure In Utero DES used as anti abortifcant from 1949-1971 500+ cases confirmed by DES Registry Usually occurred late teens
Slide 61 - Vaginal Cancer Etiology Mimics Cervical Carcinoma HPV 16 and 18
Slide 62 - Staging Stage I Confined to Vaginal Wall Stage II Subvaginal tissue but not to pelvic sidewall Stage III Extended to pelvic sidewall Stage IVA Bowel or Bladder Stage IVB Distant mets
Slide 63 - Treatment Surgery with Radical Hysterectomy and pelvic lymph dissection in selected stage I tumors high in Vagina All others treated with radiation with chemosensitization